Anthony D. Wignall

发表

Enhancement of Abiraterone Acetate Oral Bioavailability by Supersaturated-Silica Lipid Hybrids.

C. Prestidge, N. Thomas, H. B. Schultz, 2020, International journal of pharmaceutics.

Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report

J. Bowen, R. Gibson, J. Coller, 2017, Cancer Chemotherapy and Pharmacology.

Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats

J. Bowen, D. Keefe, Anthony D. Wignall, 2022, Neoplasia.

Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant

J. Bowen, D. Keefe, Anthony D. Wignall, 2020, Breast Cancer.

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model

J. Finnie, J. Bowen, D. Keefe, 2018, Cancer Chemotherapy and Pharmacology.

Vascular endothelial growth factor (VEGF), transforming growth factor beta (TGFβ), angiostatin, and endostatin are increased in radiotherapy-induced gastrointestinal toxicity

A. Stringer, N. Al-Dasooqi, J. Bowen, 2018, International journal of radiation biology.

Determining the mechanisms of lapatinib-induced diarrhoea using a rat model

F. Boyle, A. Stringer, J. Bowen, 2014, Cancer Chemotherapy and Pharmacology.

Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats.

C. Prestidge, P. Joyce, Tahnee J Dening, 2020, ACS applied bio materials.

Enhancing the Cellular Uptake and Antibacterial Activity of Rifampicin through Encapsulation in Mesoporous Silica Nanoparticles

C. Prestidge, F. Höök, P. Joyce, 2020, Nanomaterials.

Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity

C. Prestidge, J. Bowen, J. Coller, 2022, Cancer Chemotherapy and Pharmacology.

Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction

C. Prestidge, H. Albrecht, Yunmei Song, 2020, Pharmaceutics.

Chitosan Nanoparticles Facilitate Improved Intestinal Permeation and Oral Pharmacokinetics of the Mast Cell Stabiliser Cromoglycate

C. Prestidge, P. Joyce, Karl F. Peressin, 2021, International Journal of Pharmaceutics.

Selective MMP Inhibition, Using AZD3342, to Reduce Gastrointestinal Toxicity and Enhance Chemoefficacy in a Rat Model

J. Bowen, R. Gibson, Anthony D. Wignall, 2019, Chemotherapy.

Intestinal accumulation of silica particles in a rat model of dextran sulfate sodium-induced colitis

J. Bowen, R. Gibson, J. Coller, 2019, Annals of gastroenterology.

Harnessing the potential of nanostructured formulations to mimic the food effect of lurasidone.

K. Bremmell, C. Prestidge, P. Joyce, 2021, International journal of pharmaceutics.

Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles.

C. Prestidge, P. Joyce, S. Subramaniam, 2023, Journal of colloid and interface science.

The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats

C. Pietra, J. Bowen, B. Mayo, 2020, Cancer Chemotherapy and Pharmacology.

An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer's patches microfold cells.

C. Prestidge, B. Thierry, Anthony D. Wignall, 2020, International journal of pharmaceutics.

Investigation of Effect of Nutritional Drink on Chemotherapy-Induced Mucosal Injury and Tumor Growth in an Established Animal Model

E. Schiffrin, A. Stringer, J. Bowen, 2013, Nutrients.

Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections.

C. Prestidge, Z. Kopecki, N. Thomas, 2022, Nanomedicine : nanotechnology, biology, and medicine.

A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems

C. Prestidge, P. Joyce, Leah Wright, 2022, Drug Delivery and Translational Research.

Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of Pseudomonas aeruginosa Biofilm Wound Infection.

C. Prestidge, Z. Kopecki, N. Thomas, 2022, ACS infectious diseases.

An ex Vivo Model Enables Systematic Investigation of the Intestinal Absorption and Transcytosis of Oral Particulate Nanocarriers.

C. Prestidge, B. Thierry, Anthony D. Wignall, 2021, ACS biomaterials science & engineering.

Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis

E. Weaver, B. Mayo, D. Keefe, 2015, Supportive Care in Cancer.

Mesoporous Organosilica Nanoparticles to Fight Intracellular Staphylococcal Aureus Infections in Macrophages

K. Bremmell, C. Prestidge, Manasi Jambhrunkar, 2023, Pharmaceutics.

Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds

C. Prestidge, Z. Kopecki, P. Joyce, 2023, Pharmaceutics.

Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in male rats.

C. Prestidge, P. Joyce, S. Subramaniam, 2023, International journal of pharmaceutics.